1. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Issue 10289 (29th May 2021) Authors: Rovin, Brad H; Teng, Y K Onno; Ginzler, Ellen M; Arriens, Cristina; Caster, Dawn J; Romero-Diaz, Juanita; Gibson, Keisha; Kaplan, Joshua; Lisk, Laura; Navarra, Sandra; Parikh, Samir V; Randhawa, Simrat; Solomons, Neil; Huizinga, Robert B Journal: Lancet Issue: Volume 397:Issue 10289(2021) Page Start: 2070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes. Issue 3 (1st February 2019) Authors: Mackay, Meggan; Dall'Era, Maria; Fishbein, Joanna; Kalunian, Kenneth; Lesser, Martin; Sanchez‐Guerrero, Jorge; Levy, Deborah M.; Silverman, Earl; Petri, Michelle; Arriens, Cristina; Lewis, Edmund J.; Korbet, Stephen M.; Conti, Fabrizio; Tesar, Vladimir; Hruskova, Zdenka; Borba, Eduardo F.; Bonfa,... Journal: Arthritis & rheumatology Issue: Volume 71:Issue 3(2019) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome. Issue 1 (20th May 2015) Authors: Dall'Era, Maria; Levesque, Victoria; Solomons, Neil; Truman, Matt; Wofsy, David Journal: Lupus science & medicine Issue: Volume 2:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MO019AURORA PHASE 3 TRIAL DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN). (6th June 2020) Authors: Caster, Dawn J; Solomons, Neil; Randhawa, Simrat; Huizinga, Robert B Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O11 AURORA phase 3 study demonstrates voclosporin statistical superiority over standard of care in lupus nephritis (LN). (23rd March 2020) Authors: Teng, YK Onno; Parikh, Samir V; Saxena, Amit; Solomons, Neil; Huizinga, Robert B Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial. Issue 1 (31st May 2022) Authors: McDonald, Stephen; Yiu, Sean; Su, Li; Gordon, Caroline; Truman, Matt; Lisk, Laura; Solomons, Neil; Bruce, Ian N Other Names: author non-byline.; Bruce Ian N author non-byline.; Payne Katherine author non-byline.; Lunt Mark author non-byline.; Peek Niels author non-byline.; Geifman Nophar author non-byline.; Gavan Sean author non-byline.; Armitt Gillian author non-byline.; Doherty Patrick author non-byline.; Prattley J... Journal: Lupus science & medicine Issue: Volume 9:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE. Issue 5 (2nd February 2021) Authors: van Gelder, Teun; Huizinga, Robert B; Lisk, Laura; Solomons, Neil Journal: Nephrology dialysis transplantation Issue: Volume 37:Issue 5(2022) Page Start: 917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗